Lentitek secures £250k seed investment to commercialize enabling biotechnologies for advanced cancer treatments and gene therapies
Edinburgh, UK – 30 May 2023 – Edinburgh based Lentitek Ltd (Lentitek), a developer of pioneering manufacturing technologies enabling economic delivery of advanced cell and gene therapies, announced today that it has secured £250,000 ($300,000 USD) in seed investment. This investment will be deployed to further advance its technology
November 28, 2023